Summary.-An experimental tumour system for the study of metastasis has been developed using a syngeneically transplanted murine squamous carcinoma of spontaneous origin. Implants of the tumour, which does not elicit a significant immune response, grew and metastasized regularly to regional lymph nodes and lungs, in a manner comparable with that of the more malignant types of human epithelioma.
Of these, only pre-operative irradiation with 2000 rad 24 h before tumour excision produced a significant differential effect-a lower incidence of metastasis. By contrast, local radiation therapy sufficient to cause complete tumour regression but insufficient to achieve long-term local cure was shown to result in accelerated metastasis. A highly significant inhibition of metastasis was observed with the drug ICRF 159, but histological features suggested that its anti-metastatic effect in this system did not depend on morphological changes which might prevent dissemination of tumour cells.
ALTHOUGH failure to achieve local control of human cancers has been estimated to contribute to the death of about one-third of cancer patients (Suit, 1969) (Collins, Loeffler and Tivey, 1956 ). While it is true that the growth rate of many tumours may decelerate when they reach clinical proportions, the example given illustrates the fact that a very large part of the total duration of a neoplasm is subelinical, and it is therefore not surprising that many tumours have already metastasized when first diagnosed. Nonetheless, clinical experience has shown that perhaps the best single prognostic criterion in cancer is the clinical stage or the size of the tumour mass at the time of presentation. One is therefore forced to conclude that the risk of established metastatic disease increases rather dramatically in the clinical or immediate preclinical phase of growth, and cancer therapists must face the fact that they may influence the probability of metastasis by their management. In principle, it should be easy to assess the risks of a particular procedure by reference to controlled animal studies, but in practice no animal tumour system can adequately represent the human problem in every detail.
The most notable objections to the validity of many experimental tumours as models of human cancer are (i) the existence of powerful antigenic differences between tumour and host, often involving transplantation antigens; (ii) patterns of local growth and metastasis (or lack of it), which are often quite unrepresentative of human cancer; (iii) a frequent lack of histological resemblance to the commonly occurring human neoplasms; and (iv) very rapid growth rates. The first 3 of these major objections are overcome in a system which has been developed from a murine squamous carcinoma and the model has been used to investigate some of the factors which have variously been alleged to influence metastasis. In addition, the natural history of the tumour has been studied in relation to its metastatic behaviour (Peters, 1975) .
MATERIALS AND METHODS
Mice and tumour.-Female mice of the inbred albino strain WHT/Ht were used throughout these experiments. The tumour, designated Sq. Ca. " G ", arose spontaneously in the forestomach of a female mouse of the WHT/Ht strain in October 1970 and has since been maintained by serial subcutaneous transplantation and by storage in liquid N2.
Histologically, the tumour is a squamous cell carcinoma which showed extensive keratinization early in its transplant history, but for the greater part of the duration of the experiments described in this paper (representing passage numbers 53-99) it has been less well differentiated, though readily recognizable as a squamous carcinoma.
Quantitative transplantation assays of the tumour by the subcutaneous route show a TD50 (mean number of viable tumour cells required to achieve 50% " takes ") of 200-300 cells when viable cells are injected alone, and 2-7 cells when viable cells are injected in association with an excess of lethally irradiated (LI) cells. The transplantation kinetics of the tumour are consistent with single cell transplantation when excess LI cells are admixed, but are " anomalous " (Porter, Hewitt and Blake, 1973) when viable cells are injected alone, i.e. upwards of 104 cells are required for 100% successful transplantation.
In both circumstances, the median latent period between injection of cells and the formation of palpable tumours is inversely correlated with the logarithm of the number of viable cells injected.
In the experiments described in this paper, transplantation was performed intradermally. An inoculum of 10 5 cells in 0-01 ml produced, on average, discoid tumours of about 120 mm3 in 10 days. However, due in part to variable leakage of the cell suspension from a superficial intradermal injection, a spread of latent periods often occurred. In the experiments involving regional lymph node excision and putative immunization a reduced inoculum of about 2 x 104 cells was used to produce a longer exposure to tumour growth before a specific size was attained.
Preliminary experiments with the tumour system showed that local excision of primary implants in the first 5 days after inoculation, or when the tumour was no larger than 20 mm3, resulted in no metastases within a 150-day observation period. On the other hand, no mouse in which the primary implant reached a size of 200 mm3 or more, irrespective of its duration of growth, failed to develop metastases. For this reason, and to increase the analogy with human tumours which present as a function of size rather than duration, it was decided to use tumour size as the criterion for randomizing mice into their appropriate experimental group. Subsequent analysis of the data, however, indicated that the correlation of size with metastatic risk was not statistically significant within the range employed (Peters, 1975) .
The choice of a tumour size range which resulted in an intermediate risk of metastasis permitted the detection of either increased or decreased risk with different procedures.
The primary inoculation site was on the left flank of the mouse, from which metastasis, when it occurred, was most commonly to the lungs and mediastinum (97% of cases) and to the ipsilateral axillary lymph node (35%/). Mice which developed thoracic metastases were prone to sudden death due to erosion of the great vessels, but whenever possible mice were killed when they developed respiratory distress, when a metastatic node reached a size of IO0 cm diameter, or when other evidence of metastatic disease declared itself. All mice were autopsied to record the extent of metastatic disease and in the course of the experiments involving 280 autopsies, macroscopic metastatic deposits were observed in ovaries (10 cases), liver (6 cases), and kidney, adrenal, brain and bone (1 each). For the purposes of analysis, mice killed for humane reasons in a preterminal state are treated as having " died " on the same day.
Metastases were classified as predominantly thoracic or predominantly lymph nodal, according to which site was directly responsible for death or sacrifice of the mouse. Survivors were observed for at least 150 days and some for up to 12 months. In the whole series of experiments, 280 inice developed metastatic disease: of these, only 2 had a disease-free interval exceeding 100 days, so that survival for 150 days was reasonably regarded as " cure ". No mice died of causes other than metastatic disease.
Tests for tumour immunogenicity.-Mice were subjected to live cell " immunization " either by excision of a growing tumour 10 days after implantation (at a size of 30-50 mm3) or by subthreshold intradermal inoculations of live tumour cells. Fourteen days after the initial cell injection, the " immunized " mice and an age-matched group of untreated controls were challenged with subcutaneous injections of viable cells with or without added radiation killed cells. The tumour take incidence and median latent periods for palpable tumour development were recorded.
Irradiations.-Local tumour irradiations were performed 4 at a time, using a Westinghouse x-ray machine (250 kVp; 15 mA; 1-3 mm Cu h.v.l.; 494 rad/min). Mice were lightly sedated with tribromethanol (Avertin) 150 mg/kg s.c. and were placed in individual lead boxes which had been specially constructed to allow the flap of skin bearing the tumour to be drawn out from the box onto a perspex stage during the irradiation. The flap was loosely tethered to a central pillar to prevent retraction but care was taken to avoid tension which could have altered blood flow.
Tumour excisions.-Mice were anaesthe-25 tized with ether and an ellipse of skin including the tumour, with 3-5 mm margins, was excised. The cutaneous site of tumour implantation allowed clean and complete excision, and only 12/342 mice developed local recurrence. Axillary lymphadenectomy.-An arcuate incision was made along the lower border of the pectoralis major and the muscle was lifted forwards to expose the axilla. One large node was regularly present in relation to the axillary vein and in some instances a smaller second node was present. These were removed by teasing free the fatty tissue in which they were embedded. The axillary vein was not removed.
Incision biopsy.-A deep wedge of tissue including the full diameter of the tumour plus skin on either side was removed. Topical thrombin was applied if necessary to stop bleeding.
Tumour manipalation.-Tumours were gently rolled between finger and thumb for 1 min. This caused softening of the tumour followed by engorgement with blood over the next 10-15 min.
ICRF 159.-Supplies of the drug were kindly provided by Dr K. Hellmann of the Imperial Cancer Research Fund. It was given at a dose of 30 mg/kg daily i.p. or s.c. from the time of tumour inoculation till excision or irradiation.
RESULTS

Effect of " immunization " procedures
The results of attempted tumour immunization are presented in the Table. Mice in which a growing tumour had been excised before challenge showed a slight reduction in tumour takes compared with the controls or with mice which had received previous subthreshold inoculations. None of the differences is statistically significant and no significant prolongation of the tumour latent periods was observed in the " immunized " mice. It is therefore concluded that the tumour is non-immunogenic by these criteria as one would expect for a syngeneically transplanted tumour of spontaneous origin. 
Effect of non-curative irradiation
Radiation studies on the tumour system (to be reported elsewhere) indicated that the mean curative dose (TCD50) for tumours of about 90 mm3 was around 5000 rad. The fate of mice with tumours in the size range 60-120 mm3 was determined according to whether they received a dose of 4500 rad (i.e. low probability of cure) or 5500-6000 rad (high probability of cure). Both doses were sufficient to cause complete regression of tumours and only those mice in which the primary tumour site was macroscopically clear at the time of death were scored for the development of metastases. This analysis, Fig. 2 , showed that mice receiving a statistically non-curative dose had a shorter median survival time and poorer long-term survival (0/29) than mice locally "cured " by radiation (9/28) or a third group treated by surgical excision (4/25).
The implication is that microscopic recurrence of tumour contributed to the development of distant metastases (see Discussion).
Effect of ICRF 159
In the course of experiments performed in collaboration with Dr W. Boggust of St Luke's Hospital, Dublin, to assess the anti-metastatic potential of various chelating agents, a pilot study of the effect of ICRF 159 was carried out which indicated that the drug inhibited metastases in this system. Subsequent experiments confirming this finding are presented here.
Mice invasion were assessed. This author was unable to find any consistent differences in these features (Fig. 4) , nor was there any difference between the appearances of the primary growths in ICRF 159 treated mice which did or did not develop metastases. Further consideration of this topic is found in the Discussion.
DISCUSSION
Whether or not a diagnostic or therapeutic manoeuvre influences the probability of metastasis of a particular tumour will depend on the unique relationship between that tumour and its host. Extrapolation of data from one species to another, or even generalization concerning cancer of a particular site or histology in man, can be misleading. Yet to obtain insight into the risks of various procedures necessitates one or other of these approaches. When animal tumour systems are employed, biological variables can be closely controlled and accumulation of data is relatively easy, so that " significant " results are obtainable. But before accepting " significant " results from animal systems it is of paramount importance to ensure that the tumourhost system used is a reasonable model of human cancer. Such a claim can be made for the system used in these experiments.
Two important findings deserve comment in relation to previously reported results: firstly, that regional lymphadenectomy does not adversely affect survival and secondly, that pre-operative radiation is likewise not harmful and may actually be beneficial in terms of survival.
Concerning the role of the regional lymph node, the experimental work of Crile (1965 Crile ( , 1968 ) is frequently quoted. Of the systems he used, however, one is allogeneic (Sarcoma 180 in non-inbred " Swiss " mice), where H2 locus transplantation antigens were so powerful that 30% of untreated mice rejected the tumour and even then the regional node was of unique significance only in the period 4-10 days after tumour implantation. Clearly such a system cannot be considered a fair model of human cancer. In 2 other systems, nominally isologous but lacking substrain specificity, a direct comparison of radical and simple surgery showed a difference in the incidence of distant metastases in only one and here, again, the time of surgery was critical.
McCredie, Inch and Cowie (1972) found that excision or irradiation of regional lymph nodes 20 days after tumour implantation was without effect on the metastasis of either strongly or weakly antigenic tumours, while Hammond and Rolley (1970) , using a syngeneic, chemically induced mouse sarcoma which was weakly immunogenic, could not display any differences in local recurrence or distant metastasis between mice undergoing regional lymphadenectomy and controls. The present experiments, using a spontaneously arising, syngeneically transplanted squamous carcinoma with a range of exposure times, also show no adverse effect of regional lymphadenectomy, leading one to conclude that experimental evidence from representative animal tumours does not support the view that potentially involved regional lymph nodes should be left untreated.
A discussion of the question of preoperative irradiation in relation to the development of metastases has recently been provided by Scott (1972) , who identified many of the problems inherent in interpreting clinical and experimental studies. Nickson and Glicksman (1972) lamented the fact that the published experimental data " involve host-tumour reactions which may result from nonisogenic tumours as well as other factors which may be at issue. . . . The tumour system used in these experiments is free of this criticism as it arose spontaneously and has been maintained in a strictly syngeneic substrain of mice. No deleterious effect of pre-operative irradiation was observed: indeed 2000 rad given 24 h before excision was positively beneficial. These results are in accord with those of Sheldon (1974) who studied a slowly growing syngeneic mouse sarcoma 362 of spontaneous origin, as well as those of several other workers (see Perez, 1970.) Reports of increased metastases attributable to irradiation fall into 2 main groups: (i) situations where the tumours in unirradiated controls have reached such massive sizes as to cause constitutional depletion (e.g. Kaplan and Murphy, 1949) ; (ii) studies involving tumours which infiltrate diffusely rather than grow as stromated tumours (e.g. van den Brenk and Sharpington, 1971) . The consensus of data from experiments which more closely simulate the majority of human cancer leads to the conclusion that the local benefits of pre-operative irradiation need not be sacrificed for fear of promoting metastases.
Mechanical disturbance of the primary tumour by biopsy or manipulation did not significantly influence metastases in this tumour system. In general, clinical experience supports this view, e.g. Griffiths et al. (1972) found no correlation between the presence of malignant cells in peripheral or local venous blood during resection of colonic and rectal cancers and the subsequent development of metastases, although histological evidence of venous invasion did carry a worse prognosis. Growth of tumour into veins very likely increases the risk of dissemination of large emboli of tumour cells, which have been shown experimentally to be more efficient than single cells in establishing " metastases " (Thompson, 1974) , and it is logically prudent to avoid unnecessary rough handling of all neoplasms. Biopsy of cancers for diagnostic and prognostic purposes is generally accepted as a justifiable procedure although the potential hazard of opening into vessels is recognized. Clinical experience with squamous cell carcinomata at various sites, as well as the present experimental results, suggests that these tumours can be biopsied with impunity. In the case of malignant melanomata, radical excision is usually performed on the basis of a clinical diagnosis, for fear of increasing the risk of metastases. However, the evidence to support such a policy is tenuous: Jones et al. (1968) and Epstein, Bragg and Linden (1969) both found no evidence of an adverse prognosis in patients whose malignant melanomata were biopsied or locally excised before more radical treatment.
The effect of non-curative radiation on the development of metastases is most interesting. Suit, Sedlacek and Gillette (1970) and more recently Sheldon et al. (1974) reported an increased incidence of metastasis in C3H mice which developed recurrent mammary tumours after irradiation; this incidence was reduced by surgical excision of the recurrent tumour. The former authors also determined, on the basis of transplantation assays, that mice dying of metastasis with no macroscopic recurrence did not have an increased incidence of residual subclinical disease. This conclusion, based on only 11 mice because of low incidence of animals in this category, appears to conflict with the results reported here in which mice whose primary sites were macroscopically " clear" after statistically non-curative irradiation had a worse prognosis than those which were locally " cured " whether by radiation or surgery. However, the squamous cell carcinoma used in these experiments is a highly malignant tumour which may well metastasize successfully at an earlier stage in the growth of a recurrence than the less aggressive C3H mammary tumour. All these data indicate that failure to achieve local control of a primary cancer can increase the risk of metastatic disease and underline the importance of radical local cure in the overall strategy of cancer treatment.
The efficiency with which (ICRF 159 inhibited the development of metastases in this tumour system is striking. Histological studies of the Lewis lung tumour by Salsbury et al. (1970) have indicated that in mice treated with ICRF 159, the tumours showed less haemorrhagic tendency at the growing margin, and that there was a cc normalization " of the abnormal, tumour-cell lined blood vessels 363 seen in that tumour. This observation suggested that the drug might act to prevent access of malignant cells into the circulation. James and Salsbury (1974) also reported inhibition of muscle invasion by tumour in mice treated with ICRF 159 at doses of 30 mg/kg/day. In the tumour system used for these experiments, however, I could detect no consistent alteration in any of these features (Fig. 4) . This of course does not preclude some modification of the tumour microvasculature by the drug but does suggest that the morphological changes seen in the Lewis lung tumour are not essential for the antimetastatic effect of ICRF 159. Although ICRF 159 has a cytotoxic effect (Sharpe et al., 1970) it did not significantly delay the growth of primary tumour implants in these experiments. One possibility, that the drug could be significantly more toxic to cells which have entered the circulation than to those in a stromated tumour, was rejected by James and Salsbury (1974) using arguments based on drug concentrations in the blood; but the effectiveness of 5-fluorouracil (Hellman et al., 1973) in preventing metastases from the Lewis lung tumour at a dose which did not retard primary growth suggests a higher susceptibility of disseminated cells to that cytotoxic agent. Moreover, the report of Hellmann, James and Salsbury (1974) that " artificial " lung metastases from intravenously injected Lewis lung tumour cells were inhibited by ICRF 159 seems to provide direct evidence in favour of some action on the tumour cells after they have gained access to the circulation. The same authors, however, contend that a toxic effect of ICRF 159 on circulating cells cannot explain the efficacy of treatment during the first 6 days of tumour growth. This contention rests on the tenuous proposition that because no metastases develop in mice having their primary tumour implant excised in the first 5-6 days of growth one can assume that no tumour cells have disseminated during this time. It seems fair to conclude that the mechanism(s) by which ICRF 159 inhibits metastases in different systems must remain, for the present, sub judice. I 
